Consensus Boston Scientific Corporation

Stocks

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - NYSE 16:00:02 2026-08-26 EDT			Pre-market 08:13:35
48.17 ^USD	-3.39%		48.12	-0.09%

08-26	Health Care Down on Rotation Out of Biotech -- Health Care Roundup	DJ
08-26	Boston Scientific Shares Fall After Catheter Recall	MT

Evolution of the Average Target: Boston Scientific Corporation

Evolution of the Target Price: Boston Scientific Corporation

Changes in Analyst Recommendations: Boston Scientific Corporation

d51c61d9cb99645f99c4099.tgBMlOYYP4X1CJoJvFgPXbj6m4hQcNxZD8pJankj7ls._lU-88ttTvymbvFG2Qp-JY2sq-UESepqaqAgKU9M2zmASSnRpFJ-84x__Q~6eb41930432d2aef02ab902dbc23a211

Analysts' recommendations: Boston Scientific Corporation

07-31	Argus Downgrades Boston Scientific to Hold From Buy	MT
07-30	Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says	MT
07-30	Leerink Partners Adjusts Boston Scientific Price Target to $60 From $74, Maintains Outperform Rating	MT
07-30	Wells Fargo Adjusts Boston Scientific Price Target to $50 From $55, Maintains Equal Weight Rating	MT
07-30	Bernstein Adjusts Boston Scientific Price Target to $72 From $76, Maintains Outperform Rating	MT
07-30	JPMorgan Adjusts Boston Scientific Price Target to $56 From $80, Maintains Overweight Rating	MT
07-30	UBS Adjusts Boston Scientific Price Target to $67 From $74, Maintains Buy Rating	MT
07-30	Baird Adjusts Price Target on Boston Scientific to $53 From $64, Maintains Outperform Rating	MT
07-30	TD Cowen Adjusts Price Target on Boston Scientific to $56 From $61, Maintains Buy Rating	MT
07-30	Jefferies Adjusts Price Target on Boston Scientific to $60 From $67, Maintains Buy Rating	MT
07-30	Canaccord Genuity Adjusts Price Target on Boston Scientific to $66 From $70, Maintains Buy Rating	MT
07-30	Mizuho Adjusts Price Target on Boston Scientific to $60 From $70, Maintains Outperform Rating	MT
07-30	Raymond James Adjusts Price Target on Boston Scientific to $57 From $78, Maintains Outperform Rating	MT
07-30	RBC Cuts Price Target on Boston Scientific to $70 From $85, Keeps Outperform Rating	MT
07-30	Rothschild & Co Redburn Adjusts Price Target on Boston Scientific to $78 From $106, Maintains Buy Rating	MT
07-30	Deutsche Bank Adjusts Boston Scientific PT to $60 From $75, Maintains Buy Rating	MT
07-30	The Fed Gets a Better Inflation Number
07-30	Truist Cuts Price Target on Boston Scientific to $57 From $62, Keeps Buy Rating	MT
07-30	Analysts recommendations: Humana, Lam Research, Procter & Gamble, Carvana, Fair Isaac…
07-29	Piper Sandler Adjusts Price Target on Boston Scientific to $60 From $65	MT
07-28	Boston Scientific Has Underappreciated Growth Drivers, UBS Says	MT
07-28	UBS Adjusts Price Target on Boston Scientific to $74 From $95, Maintains Buy Rating	MT
07-27	Boston Scientific Continues to See Competitive Pressures, Oppenheimer Says	MT
07-27	Oppenheimer Trims Price Target on Boston Scientific to $85 From $90, Keeps Outperform Rating	MT
07-16	Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BOSTON SCIENTIFIC CORPORATION					+30.14%
	THERMO FISHER SCIENTIFIC, INC.					-0.36%
	DANAHER CORPORATION					+5.85%
	INTUITIVE SURGICAL, INC.					+29.05%
	EDWARDS LIFESCIENCES CORPORATION					+11.22%
	SIEMENS HEALTHINEERS AG					+14.86%
	AGILENT TECHNOLOGIES, INC.					+3.72%
	WATERS CORPORATION					+5.27%
	RESMED, INC.					+4.16%
	ILLUMINA, INC.					-11.54%
	Average					+9.24%
	Weighted average by Cap.					+9.71%